Mironid is currently owned by Sofinnova Partners, through Sofinnova Capital X, since 2021.

When did Sofinnova Partners acquire Mironid?

Sofinnova Partners acquired Mironid in 2021 (active for 5 years).

Home/Companies/Biotech/Mironid

Mironid

Biotech·

UK·Active·5yr hold

Mironid is a healthcare / biotech company, headquartered in United Kingdom.

Entry

2021

Hold

5yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQUnited Kingdom

SectorHealthcare / Biotech

Glasgow-based company developing cAMP phosphodiesterase inhibitors targeting cell signaling pathways for inflammatory and fibrotic diseases.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings